Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma

ObjectiveDespite several clinicopathological factors being integrated as prognostic biomarkers, the individual variants and risk stratification have not been fully elucidated in lower grade glioma (LGG). With the prevalence of gene expression profiling in LGG, and based on the critical role of the i...

Full description

Bibliographic Details
Main Authors: Mingwei Zhang, Xuezhen Wang, Xiaoping Chen, Qiuyu Zhang, Jinsheng Hong
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00363/full
_version_ 1819105245719953408
author Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Xuezhen Wang
Xiaoping Chen
Qiuyu Zhang
Jinsheng Hong
Jinsheng Hong
Jinsheng Hong
author_facet Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Xuezhen Wang
Xiaoping Chen
Qiuyu Zhang
Jinsheng Hong
Jinsheng Hong
Jinsheng Hong
author_sort Mingwei Zhang
collection DOAJ
description ObjectiveDespite several clinicopathological factors being integrated as prognostic biomarkers, the individual variants and risk stratification have not been fully elucidated in lower grade glioma (LGG). With the prevalence of gene expression profiling in LGG, and based on the critical role of the immune microenvironment, the aim of our study was to develop an immune-related signature for risk stratification and prognosis prediction in LGG.MethodsRNA-sequencing data from The Cancer Genome Atlas (TCGA), Genome Tissue Expression (GTEx), and Chinese Glioma Genome Atlas (CGGA) were used. Immune-related genes were obtained from the Immunology Database and Analysis Portal (ImmPort). Univariate, multivariate cox regression, and Lasso regression were employed to identify differentially expressed immune-related genes (DEGs) and establish the signature. A nomogram was constructed, and its performance was evaluated by Harrell’s concordance index (C-index), receiver operating characteristic (ROC), and calibration curves. Relationships between the risk score and tumor-infiltrating immune cell abundances were evaluated using CIBERSORTx and TIMER.ResultsNoted, 277 immune-related DEGs were identified. Consecutively, 6 immune genes (CANX, HSPA1B, KLRC2, PSMC6, RFXAP, and TAP1) were identified as risk signature and Kaplan–Meier curve, ROC curve, and risk plot verified its performance in TCGA and CGGA datasets. Univariate and multivariate Cox regression indicated that the risk group was an independent predictor in primary LGG. The prognostic signature showed fair accuracy for 3- and 5-year overall survival in both internal (TCGA) and external (CGGA) validation cohorts. However, predictive performance was poor in the recurrent LGG cohort. The CIBERSORTx algorithm revealed that naïve CD4+ T cells were significant higher in low-risk group. Conversely, the infiltration levels of M1-type macrophages, M2-type macrophages, and CD8+T cells were significant higher in high-risk group in both TCGA and CGGA cohorts.ConclusionThe present study constructed a robust six immune-related gene signature and established a prognostic nomogram effective in risk stratification and prediction of overall survival in primary LGG.
first_indexed 2024-12-22T02:19:11Z
format Article
id doaj.art-cc30273112c14b35841e3eb19cd63ac9
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-22T02:19:11Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-cc30273112c14b35841e3eb19cd63ac92022-12-21T18:42:11ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-04-011110.3389/fgene.2020.00363523455Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade GliomaMingwei Zhang0Mingwei Zhang1Mingwei Zhang2Mingwei Zhang3Mingwei Zhang4Xuezhen Wang5Xiaoping Chen6Qiuyu Zhang7Jinsheng Hong8Jinsheng Hong9Jinsheng Hong10Department of Radiation Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaInstitute of Immunotherapy, Fujian Medical University, Fuzhou, ChinaKey Laboratory of Radiation Biology (Fujian Medical University), Fujian Province University, Fuzhou, ChinaFujian Key Laboratory of Individualized Active Immunotherapy, Fuzhou, ChinaFujian Medical University Union Hospital, Fuzhou, ChinaDepartment of Radiation Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Statistics, College of Mathematics and Informatics & FJKLMAA, Fujian Normal University, Fuzhou, ChinaInstitute of Immunotherapy, Fujian Medical University, Fuzhou, ChinaDepartment of Radiation Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaKey Laboratory of Radiation Biology (Fujian Medical University), Fujian Province University, Fuzhou, ChinaFujian Key Laboratory of Individualized Active Immunotherapy, Fuzhou, ChinaObjectiveDespite several clinicopathological factors being integrated as prognostic biomarkers, the individual variants and risk stratification have not been fully elucidated in lower grade glioma (LGG). With the prevalence of gene expression profiling in LGG, and based on the critical role of the immune microenvironment, the aim of our study was to develop an immune-related signature for risk stratification and prognosis prediction in LGG.MethodsRNA-sequencing data from The Cancer Genome Atlas (TCGA), Genome Tissue Expression (GTEx), and Chinese Glioma Genome Atlas (CGGA) were used. Immune-related genes were obtained from the Immunology Database and Analysis Portal (ImmPort). Univariate, multivariate cox regression, and Lasso regression were employed to identify differentially expressed immune-related genes (DEGs) and establish the signature. A nomogram was constructed, and its performance was evaluated by Harrell’s concordance index (C-index), receiver operating characteristic (ROC), and calibration curves. Relationships between the risk score and tumor-infiltrating immune cell abundances were evaluated using CIBERSORTx and TIMER.ResultsNoted, 277 immune-related DEGs were identified. Consecutively, 6 immune genes (CANX, HSPA1B, KLRC2, PSMC6, RFXAP, and TAP1) were identified as risk signature and Kaplan–Meier curve, ROC curve, and risk plot verified its performance in TCGA and CGGA datasets. Univariate and multivariate Cox regression indicated that the risk group was an independent predictor in primary LGG. The prognostic signature showed fair accuracy for 3- and 5-year overall survival in both internal (TCGA) and external (CGGA) validation cohorts. However, predictive performance was poor in the recurrent LGG cohort. The CIBERSORTx algorithm revealed that naïve CD4+ T cells were significant higher in low-risk group. Conversely, the infiltration levels of M1-type macrophages, M2-type macrophages, and CD8+T cells were significant higher in high-risk group in both TCGA and CGGA cohorts.ConclusionThe present study constructed a robust six immune-related gene signature and established a prognostic nomogram effective in risk stratification and prediction of overall survival in primary LGG.https://www.frontiersin.org/article/10.3389/fgene.2020.00363/fulllower grade gliomaThe Cancer Genome AtlasChinese Glioma Genome Atlasimmune-related signatureprognosis
spellingShingle Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Mingwei Zhang
Xuezhen Wang
Xiaoping Chen
Qiuyu Zhang
Jinsheng Hong
Jinsheng Hong
Jinsheng Hong
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
Frontiers in Genetics
lower grade glioma
The Cancer Genome Atlas
Chinese Glioma Genome Atlas
immune-related signature
prognosis
title Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
title_full Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
title_fullStr Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
title_full_unstemmed Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
title_short Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
title_sort novel immune related gene signature for risk stratification and prognosis of survival in lower grade glioma
topic lower grade glioma
The Cancer Genome Atlas
Chinese Glioma Genome Atlas
immune-related signature
prognosis
url https://www.frontiersin.org/article/10.3389/fgene.2020.00363/full
work_keys_str_mv AT mingweizhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT mingweizhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT mingweizhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT mingweizhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT mingweizhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT xuezhenwang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT xiaopingchen novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT qiuyuzhang novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT jinshenghong novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT jinshenghong novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma
AT jinshenghong novelimmunerelatedgenesignatureforriskstratificationandprognosisofsurvivalinlowergradeglioma